These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33340991)

  • 1. Discoidin domain receptor 1 activation links extracellular matrix to podocyte lipotoxicity in Alport syndrome.
    Kim JJ; David JM; Wilbon SS; Santos JV; Patel DM; Ahmad A; Mitrofanova A; Liu X; Mallela SK; Ducasa GM; Ge M; Sloan AJ; Al-Ali H; Boulina M; Mendez AJ; Contreras GN; Prunotto M; Sohail A; Fridman R; Miner JH; Merscher S; Fornoni A
    EBioMedicine; 2021 Jan; 63():103162. PubMed ID: 33340991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of collagen-receptor DDR1 delays renal fibrosis in hereditary type IV collagen disease.
    Gross O; Girgert R; Beirowski B; Kretzler M; Kang HG; Kruegel J; Miosge N; Busse AC; Segerer S; Vogel WF; Müller GA; Weber M
    Matrix Biol; 2010 Jun; 29(5):346-56. PubMed ID: 20307660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glomerular basement membrane deposition of collagen α1(III) in Alport glomeruli by mesangial filopodia injures podocytes via aberrant signaling through DDR1 and integrin α2β1.
    Madison J; Wilhelm K; Meehan DT; Delimont D; Samuelson G; Cosgrove D
    J Pathol; 2022 Sep; 258(1):26-37. PubMed ID: 35607980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
    Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
    Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Extracellular Matrix Receptor Discoidin Domain Receptor 1 Regulates Collagen Transcription by Translocating to the Nucleus.
    Chiusa M; Hu W; Liao HJ; Su Y; Borza CM; de Caestecker MP; Skrypnyk NI; Fogo AB; Pedchenko V; Li X; Zhang MZ; Hudson BG; Basak T; Vanacore RM; Zent R; Pozzi A
    J Am Soc Nephrol; 2019 Sep; 30(9):1605-1624. PubMed ID: 31383731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA-Encoded Library-Derived DDR1 Inhibitor Prevents Fibrosis and Renal Function Loss in a Genetic Mouse Model of Alport Syndrome.
    Richter H; Satz AL; Bedoucha M; Buettelmann B; Petersen AC; Harmeier A; Hermosilla R; Hochstrasser R; Burger D; Gsell B; Gasser R; Huber S; Hug MN; Kocer B; Kuhn B; Ritter M; Rudolph MG; Weibel F; Molina-David J; Kim JJ; Santos JV; Stihle M; Georges GJ; Bonfil RD; Fridman R; Uhles S; Moll S; Faul C; Fornoni A; Prunotto M
    ACS Chem Biol; 2019 Jan; 14(1):37-49. PubMed ID: 30452219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discoidin domain receptor 1-deletion ameliorates fibrosis and promotes adipose tissue beiging, brown fat activity, and increased metabolic rate in a mouse model of cardiometabolic disease.
    Lino M; Ngai D; Liu A; Mohabeer A; Harper C; Caruso LL; Schroer SA; Fu F; McKee T; Giacca A; Woo M; Bendeck MP
    Mol Metab; 2020 Sep; 39():101006. PubMed ID: 32360427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of discoidin domain receptor 2 in the renal dysfunction of alport syndrome mouse model.
    Sannomiya Y; Kaseda S; Kamura M; Yamamoto H; Yamada H; Inamoto M; Kuwazuru J; Niino S; Shuto T; Suico MA; Kai H
    Ren Fail; 2021 Dec; 43(1):510-519. PubMed ID: 33706638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.
    Borza CM; Su Y; Tran TL; Yu L; Steyns N; Temple KJ; Skwark MJ; Meiler J; Lindsley CW; Hicks BR; Leitinger B; Zent R; Pozzi A
    Matrix Biol; 2017 Jan; 57-58():258-271. PubMed ID: 27915093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
    Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
    J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
    Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
    Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-α drives Alport glomerulosclerosis in mice by promoting podocyte apoptosis.
    Ryu M; Mulay SR; Miosge N; Gross O; Anders HJ
    J Pathol; 2012 Jan; 226(1):120-31. PubMed ID: 21953121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated expression of integrin α1 in mesangial cells and integrin α3 and vimentin in podocytes of Col4a3-null (Alport) mice.
    Steenhard BM; Vanacore R; Friedman D; Zelenchuk A; Stroganova L; Isom K; St John PL; Hudson BG; Abrahamson DR
    PLoS One; 2012; 7(12):e50745. PubMed ID: 23236390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective pharmacological inhibition of DDR1 prevents experimentally-induced glomerulonephritis in prevention and therapeutic regime.
    Moll S; Yasui Y; Abed A; Murata T; Shimada H; Maeda A; Fukushima N; Kanamori M; Uhles S; Badi L; Cagarelli T; Formentini I; Drawnel F; Georges G; Bergauer T; Gasser R; Bonfil RD; Fridman R; Richter H; Funk J; Moeller MJ; Chatziantoniou C; Prunotto M
    J Transl Med; 2018 Jun; 16(1):148. PubMed ID: 29859097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empagliflozin reduces podocyte lipotoxicity in experimental Alport syndrome.
    Ge M; Molina J; Kim JJ; Mallela SK; Ahmad A; Varona Santos J; Al-Ali H; Mitrofanova A; Sharma K; Fontanesi F; Merscher S; Fornoni A
    Elife; 2023 May; 12():. PubMed ID: 37129368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDR1 (Discoidin Domain Receptor-1)-RhoA (Ras Homolog Family Member A) Axis Senses Matrix Stiffness to Promote Vascular Calcification.
    Ngai D; Lino M; Rothenberg KE; Simmons CA; Fernandez-Gonzalez R; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2020 Jul; 40(7):1763-1776. PubMed ID: 32493168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagen stimulates discoidin domain receptor 1-mediated migration of smooth muscle cells through Src.
    Lu KK; Trcka D; Bendeck MP
    Cardiovasc Pathol; 2011; 20(2):71-6. PubMed ID: 20093046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic Vascular Calcification Mediated by the Collagen Receptor Discoidin Domain Receptor 1 via the Phosphoinositide 3-Kinase/Akt/Runt-Related Transcription Factor 2 Signaling Axis.
    Lino M; Wan MH; Rocca AS; Ngai D; Shobeiri N; Hou G; Ge C; Franceschi RT; Bendeck MP
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1878-1889. PubMed ID: 29930002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDR1 contributes to kidney inflammation and fibrosis by promoting the phosphorylation of BCR and STAT3.
    Borza CM; Bolas G; Bock F; Zhang X; Akabogu FC; Zhang MZ; de Caestecker M; Yang M; Yang H; Lee E; Gewin L; Fogo AB; McDonald WH; Zent R; Pozzi A
    JCI Insight; 2022 Feb; 7(3):. PubMed ID: 34941574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synaptopodin deficiency exacerbates kidney disease in a mouse model of Alport syndrome.
    Ning L; Suleiman HY; Miner JH
    Am J Physiol Renal Physiol; 2021 Jul; 321(1):F12-F25. PubMed ID: 34029143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.